The monoclonal antibody of the isolation of binding human tissue factor pathway inhibitor (TFPI) is provided. It also include the isolated nucleic acid molecule encoding monoclonal antibody of binding TFPI. Additionally provide pharmaceutical compositions comprising anti-TFPI monoclonal antibodies and method, undertreatment or defect in the condensation by the management of antibody. Additionally provide the method for generating antibody.